Skip to main content

Immunovant, Inc.

IMVT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001764013

In the last 90 days, Immunovant, Inc. insiders filed 0 open-market purchases and 10 sales; 226 institutions reported holding it in 13F filings for Q2 2026, worth $4.25B in total; Greenlight Capital is the only superinvestor holding it.

Q2 2022 vs. Q1 2022

How the institutions holding Immunovant, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of IMVT: Q1 2022 compared with Q2 2022
MeasureQ1 2022Of which not filed for Q2 2022Q2 2022Change
Holders112494−14
Shares39.6M167.0K40.1M+744.9K (+1.9%)
Value$218.6M$921.0K$156.5M−$61.2M (−28.1%)

4 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (12)

Institutions that held Immunovant, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to IMVT in Q2 2022
InstitutionSharesValue% of portfolio
Woodline Partners LP92,100$359.0K0.01%
New York Life Investment Management LLC84,635$330.0K0.00%
Allspring Global Investments Holdings, LLC49,161$191.0K0.00%
Gsa Capital Partners LLP39,817$155.0K0.02%
SG Americas Securities, LLC22,622$88.0K0.00%
Ergoteles LLC14,926$58.0K0.00%
Mirae Asset Global Investments Co., Ltd.14,532$57.0K0.00%
UBS Group AG2,283$9.00K0.00%
Wells Fargo & Company520$2.00K0.00%
Simplex Trading, LLC55$00.00%
Rockefeller Capital Management L.P.224$00.00%
PEAK6 Investments LLC13,000––

Sold out (26)

Institutions that held Immunovant, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Not filed for Q2 2022 yet (4)

Institutions that held Immunovant, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IMVT in Q1 2022 that haven't filed for Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Virginia Retirement Systems Et Al76,200$420.0K
IndexIQ Advisors LLC71,281$393.0K
Parametric Portfolio Associates LLC13,590$75.0K
Amalgamated Financial Corp.5,943$33.0K